John Trizzino, EVP, CCO, CBO & Interim CFO at NOVAVAX INC (NVAX), sold 4,500 shares at $188.51 ($835K) on 2021-05-05, disclosed to the SEC on 2021-05-07.
Open-market sale of $835k NVAX by EVP, CCO, CBO & Interim CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $163.03 | 72 | $12K | 1.4% |
| 2 | $164.71 | 12 | $2K | 0.2% |
| 3 | $168.34 | 13 | $2K | 0.3% |
| 4 | $169.70 | 93 | $16K | 1.9% |
| 5 | $171.09 | 208 | $36K | 4.3% |
| 6 | $171.74 | 14 |
| $2K |
| 0.3% |
| 7 | $171.74 | 180 | $31K | 3.7% |
| 8 | $171.89 | 28 | $5K | 0.6% |
| 9 | $180.37 | 70 | $13K | 1.5% |
| 10 | $181.17 | 85 | $15K | 1.8% |
| 11 | $182.45 | 160 | $29K | 3.5% |
| 12 | $183.43 | 138 | $25K | 3.0% |
| 13 | $184.25 | 252 | $46K | 5.6% |
| 14 | $186.05 | 105 | $20K | 2.3% |
| 15 | $187.35 | 186 | $35K | 4.2% |
| 16 | $188.51 | 318 | $60K | 7.2% |
| 17 | $188.51 | 318 | $60K | 7.2% |
| 18 | $189.46 | 364 | $69K | 8.3% |
| 19 | $189.46 | 364 | $69K | 8.3% |
| 20 | $190.62 | 192 | $37K | 4.4% |
| 21 | $191.53 | 412 | $79K | 9.4% |
| 22 | $191.53 | 412 | $79K | 9.4% |
| 23 | $192.81 | 246 | $47K | 5.7% |
| 24 | $194.08 | 68 | $13K | 1.6% |
| 25 | $176.60 | 90 | $16K | 1.9% |
| 26 | $176.65 | 100 | $18K | 2.1% |
| Total | $185.59 avg | 4,500 | $835K | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-04-07 | $1.2M | — | Filing → |